The first nuclear output inhibitor Xpovio 3 indications was accepted by the FDA in the United States.
-
Last Update: 2020-07-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Original source: U.SFood and Drug Administration Accept SKaryopharm's Supplemental New Drug Application for XPOVIO ® (selinexor) as a Treatment for patients with Multiple Myeloma Mae At Os One FirstLine of Therapy original title: myeloma oral new drug! The first nuclear output inhibitor Xpovio 3rd indicationisreceived by the FDA, Deqi Pharmaceuticals was introduced into China for development!
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
